COVID-19 Vaccines
Part II: Debunking COVID-19 Vaccine Myths with Facts
3 min read
By Apollo 24/7, Published on - 09 February 2021, Updated on - 18 October 2022
Share this article
1
5 likes
COVID-19 Vaccines: Myths and Facts
Myth #1: People who have recovered from COVID-19 don’t need vaccines
Myth #2: People with underlying medical conditions shouldn’t get a COVID-19 vaccine
Myth #3: Healthy people with good immune function don’t need a COVID-19 vaccine
Myth #4: People who have received the COVID-19 vaccines will test positive for the virus
Myth #5: People who have received COVID-19 vaccines can stop wearing masks
Conclusion
COVID-19 Vaccines
Leave Comment
Recommended for you
COVID-19 Vaccines
ZyCoV-D: The world’s first DNA plasmid-based COVID-19 vaccine
ZyCoV-D is the sixth vaccine to be approved in India and the only one to be approved for adolescents in the 12 to 18 years age group.
COVID-19 Vaccines
How COVID-19 Vaccination Drives are Expected to be Organized
Once a vaccine is approved, the next big challenge will be to ensure effective vaccine distribution and delivery.
COVID-19 Vaccines
Which COVID-19 vaccines have applied for emergency authorization in India?
After receiving Emergency Use Approval (EUA) in the United Kingdom, Pfizer has now approached the Indian and the U.S government for the same.
Subscribe
Sign up for our free Health Library Daily Newsletter
Get doctor-approved health tips, news, and more.
Visual Stories
COVID-19 Vaccine Factbox: Johnson & Johnson
Tap to continue exploring
Recommended for you
COVID-19 Vaccines
ZyCoV-D: The world’s first DNA plasmid-based COVID-19 vaccine
ZyCoV-D is the sixth vaccine to be approved in India and the only one to be approved for adolescents in the 12 to 18 years age group.
COVID-19 Vaccines
How COVID-19 Vaccination Drives are Expected to be Organized
Once a vaccine is approved, the next big challenge will be to ensure effective vaccine distribution and delivery.
COVID-19 Vaccines
Which COVID-19 vaccines have applied for emergency authorization in India?
After receiving Emergency Use Approval (EUA) in the United Kingdom, Pfizer has now approached the Indian and the U.S government for the same.